Sammanfattning
BACKGROUND Clinical studies from other countries show that self-management of warfarin therapy may reduce the risk of mortality, thromboembolism and
complications when compared to conventional therapy. The purpose of this study was to train patients in self-management and compare the results with
conventional therapy in Norway.
METHOD A total of 23 patients who had previously been given conventional therapy by their GPs were instructed in how to measure INR (using the CoaguChek
XS device) and administer warfarin dosage through a structured training programme over the course of 27 weeks. The participants continued with self-
management for a further 28 weeks after the end of the training period. The time in the therapeutic range (TTR, measured as a percentage) was calculated and the
TTR for conventional therapy and self-management were compared.
RESULTS No significant difference in average TTR was found when comparing conventional therapy (70 % (95 % confidence interval (CI) 62 - 78)) with the self-
management period (75 % (95 % CI 69 - 81, p = 0.24)). The percentage of extreme INR values (< 1.5 or > 5.0) was higher during conventional therapy than during
self-management (6.8 % vs. 1.0 %, p < 0.001).
INTERPRETATION No significant difference in TTR was found when comparing self-management and conventional warfarin therapy in our study, but for self-
management there was a lower percentage of extreme INR values compared to conventional warfarin therapy.